Evolent Health, Inc (EVH) financial statements (2020 and earlier)

Company profile

Business Address 800 NORTH GLEBE RD, SUITE 500
ARLINGTON, VA 22203
State of Incorp. DE
Fiscal Year End December 31
SIC 8741 - Management Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:103206137228228267254
Cash and cash equivalents1019793171228222198
Short-term investments2442   
Other undisclosed cash, cash equivalents, and short-term investments 1054055 4556
Restricted cash and investments2010139511554254
Receivables72727064785883
Contract with customer, asset2111243
Other undisclosed current assets32(73)(6)(22)24(22)(41)
Total current assets:229308241321488349353
Noncurrent Assets
Operating lease, right-of-use asset727677 
Property, plant and equipment85838077746965
Long-term investments and receivables1407179241364
Long-term investments139717218664
Accounts and financing receivable, after allowance for credit loss10777  
Intangible assets, net (including goodwill)8811,0891,0991,1071,103866872
Goodwill572772772770768635635
Intangible assets, net (excluding goodwill)308317327336335231237
Contract with customer, asset, net1112111
Capitalized contract cost, net36302422191411
Restricted cash and investments8877633
Other noncurrent assets 81111 1512
Other undisclosed noncurrent assets4640335718  
Total noncurrent assets:1,2691,4061,4111,3081,234974968
TOTAL ASSETS:1,4981,7141,6521,6291,7221,3231,322
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10618910810822110797
Accounts payable3712029391473134
Accrued liabilities33425353494739
Employee-related liabilities35272716252923
Deferred revenue202327 
Debt655    
Due to related parties 101157
Contract with customer, liability22212230
Other undisclosed current liabilities614233322763
Total current liabilities:193260173164269139136
Noncurrent Liabilities
Long-term debt and lease obligation697171    
Operating lease, liability697171 
Liabilities, other than long-term debt15313611191212
Deferred revenue100 
Contract with customer, liability0211
Deferred income tax liabilities22526 
Other liabilities1271010171111
Other undisclosed noncurrent liabilities292228225305245123122
Total noncurrent liabilities:376330333316264135134
Total liabilities:569590506479533274270
Stockholders' equity
Stockholders' equity attributable to parent, including:9221,1081,1311,1001,1441,0391,041
Additional paid in capital1,1741,1621,1581,0961,093971961
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)(0)
Retained earnings (accumulated deficit)(252)(54)(28)3506779
Other undisclosed stockholders' equity attributable to parent1111111
Stockholders' equity attributable to noncontrolling interest7161650461010
Total stockholders' equity:9291,1241,1471,1501,1891,0491,051
TOTAL LIABILITIES AND EQUITY:1,4981,7141,6521,6291,7221,3231,322

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues237220192198193150144
Other undisclosed gross profit    (1)  
Gross profit:237220192198192150144
Operating expenses(451)(240)(217)(244)(206)(161)(153)
Other undisclosed operating income    1  
Operating loss:(215)(20)(25)(47)(13)(11)(9)
Nonoperating income1101111
Investment income, nonoperating1111111
Other nonoperating income (expense)(0)(0)(1)00(0)0
Interest and debt expense(4)(4)(4)(4)(3)(1)(1)
Loss from continuing operations before equity method investments, income taxes:(218)(23)(29)(49)(16)(11)(9)
Loss from equity method investments(3)(4)(2)(0)(2)(1)(1)
Loss from continuing operations before income taxes:(221)(27)(31)(49)(18)(12)(10)
Income tax expense (benefit)221(1)0(0)(0)0
Net loss:(199)(26)(32)(49)(18)(13)(10)
Net income attributable to noncontrolling interest1002100
Net loss available to common stockholders, diluted:(198)(26)(32)(47)(17)(12)(10)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(199)(26)(32)(49)(18)(13)(10)
Other undisclosed comprehensive income (loss)(0)(0)000(0)(0)
Comprehensive loss:(199)(26)(32)(49)(17)(13)(10)
Comprehensive income, net of tax, attributable to noncontrolling interest1002100
Comprehensive loss, net of tax, attributable to parent:(198)(26)(32)(47)(17)(13)(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: